Categories: AnalystsTech Triangle

Ahead of Q2 numbers, Cormark raises target on Open Text

Open Text CEO Mark BarrenecheaDespite a 66% gain in 2013, the coming year looks more than promising for Open Text (TSX:OTC) because it finally may have a more balanced mix of acquisition and organic growth, says Comark analyst Richard Tse.

On Thursday, after market close, Open Text will report its Q2, 2014 results. The company is following on a Q1 in which it posted net income of $30.6 million, or $1.37 a share on revenue of $324.5-million.

Tse believes Open Text will post earnings of $1.48 per share on revenue of $353-million in its upcoming Q2.

Tse says Open Text has climbed for the better part of seven years on a growth-by-acquisition strategy. But today, the Cormark analyst says the more elusive organic growth may finally become a driver of the stock, due to its “Red Oxygen” and “Blue Carbon” initiatives.

At Open Text’s user conference in November, much of the talk was about the company’s recently closed $1.16-billion acquisition of GXS Group. GXS, known primarily an operator of EDI (Electronic Data Interchange) networks quietly gives Open Text a majority share of the EDI market, says Tse.

But Red Oxygen and Blue Carbon, respective code names for OpenText’s current line of products and a future line of products that build on the former, have the potential to drive future organic growth that Tse believes are not being priced into the stock.

In a research update to clients this morning, Tse maintained his BUY rating and increased his one-year price target on OpenText to $110, up from his previous target of $95. This target, he explains, implies a valuation of a shade under 17x his fiscal 2015 earnings estimate of $6.55.

_____________________________________________________________________________________________________________________

We Hate Paywalls Too!

At Cantech Letter we prize independent journalism like you do. And we don't care for paywalls and popups and all that noise That's why we need your support. If you value getting your daily information from the experts, won't you help us? No donation is too small.

Make a one-time or recurring donation

Tagged with: OTC
Nick Waddell

Cantech Letter founder and editor Nick Waddell has lived in five Canadian provinces and is proud of his country's often overlooked contributions to the world of science and technology. Waddell takes a regular shift on the Canadian media circuit, making appearances on CTV, CBC and BNN, and contributing to publications such as Canadian Business and Business Insider.

Recent Posts

Is GOOGL still a buy?

Following a widely applauded first quarter beat, Roth MKM analyst Rohit Kulkarni has maintained his "Buy" rating on Alphabet (Alphabet… [Read More]

4 hours ago

NLH has 173% upside, Echelon says

Following an acquisition, Echelon Capital Markets analyst Stefan Quenneville has maintained his "Buy" rating on Nova Leap Health (Nova Leap… [Read More]

5 hours ago

Shopify upgraded to “Buy” at Citi

The stock has been flat since November, but Citi analyst Tyler Radke thinks there is now money to be made… [Read More]

5 hours ago

Sabio has 400% upside, Eight Capital says

Following the company's fourth quarter results, Eight Capital analyst Kiran Sritharan has maintained his "Buy" rating on Sabio Holdings (Sabio… [Read More]

3 days ago

Is SNAP a buy right now?

He feels the company made forward progress in its recent quarterly results, but Roth MKM analyst Rohit Kulkarni wants to… [Read More]

3 days ago

Bombardier wins price target raise at Desjardins

Following the company's first quarter results, Desjardins analyst Benoit Poirier has raised his price target on Bombardier (Bombardier Stock Quote,… [Read More]

3 days ago